Comparison between F-18-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature

被引：11
作者：
Mirk, Paoletta [1 ]
Treglia, Giorgio [2 ]
Salsano, Marco [2 ]
Basile, Pietro [2 ]
Giordano, Alessandro [2 ]
Bonomo, Lorenzo [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Inst Radiol, Dept Bioimaging & Radiol Sci, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Inst Nucl Med, Dept Bioimaging & Radiol Sci, I-00168 Rome, Italy
来源：
RADIOLOGY RESEARCH AND PRACTICE | 2011年 / 2011卷
关键词：
D O I：
10.1155/2011/912504
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Aim. to compare F-18-Fluorodeoxyglucose positron emission tomography (FDG-PET) to sentinel lymph node biopsy (SLNB) for regional lymph nodal staging in patients with melanoma. Methods. We performed a literature review discussing original articles which compared FDG-PET to SLNB for regional lymph nodal staging in patients with melanoma. Results and Conclusions. There is consensus in the literature that FDG-PET cannot replace SLNB for regional lymph nodal staging in patients with melanoma.
引用
收藏
页数：5
相关论文
共 21 条
[1]   Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma [J].
Acland, KM ;
Healy, C ;
Calonje, E ;
O'Doherty, M ;
Nunan, T ;
Page, C ;
Higgins, E ;
Russell-Jones, R .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2674-2678
[2]   Staging of regional nodes in AJCC stage I and II melanoma:: 18FDG PET imaging versus sentinel node detection [J].
Belhocine, T ;
Pierard, G ;
de Labrassinne, M ;
Lahaye, T ;
Rigo, P .
ONCOLOGIST, 2002, 7 (04) :271-278
[3]   Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma [J].
Clark, PB ;
Soo, V ;
Kraas, J ;
Shen, P ;
Levine, EA .
ARCHIVES OF SURGERY, 2006, 141 (03) :284-288
[4]   Melanoma [J].
Coit, Daniel G. ;
Andtbacka, Robert ;
Bichakjian, Christopher K. ;
Dilawari, Raza A. ;
DiMaio, Dominick ;
Guild, Valerie ;
Halpern, Allan C. ;
Hodi, F. Stephen ;
Kashani-Sabet, Mohammed ;
Lange, Julie R. ;
Lind, Anne ;
Martin, Lainie ;
Martini, Mary C. ;
Pruitt, Scott K. ;
Ross, Merrick I. ;
Sener, Stephen F. ;
Swetter, Susan M. ;
Tanabe, Kenneth K. ;
Thompson, John A. ;
Trisal, Vijay ;
Urist, Marshall M. ;
Weber, Jeffrey ;
Wong, Michael K. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (03) :250-275
[5]   Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II [J].
Fink, AM ;
Holle-Robatsch, S ;
Herzog, N ;
Mirzaei, S ;
Rappersberger, K ;
Lilgenau, N ;
Jurecka, W ;
Steiner, A .
MELANOMA RESEARCH, 2004, 14 (02) :141-145
[6]   Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients [J].
Gershenwald, JE ;
Thompson, W ;
Mansfield, PF ;
Lee, JE ;
Colome, MI ;
Tseng, CH ;
Lee, JJ ;
Balch, CM ;
Reintgen, DS ;
Ross, MI .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :976-983
[7]   Baseline staging in cutaneous malignant melanoma [J].
Hafner, J ;
Schmid, MH ;
Kempf, W ;
Burg, G ;
Künzi, W ;
Meuli-Simmen, C ;
Neff, P ;
Meyer, V ;
Mihic, D ;
Garzoli, E ;
Jungius, KP ;
Siefert, B ;
Dummer, R .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (04) :677-686
[8]   Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma [J].
Havenga, K ;
Cobben, DCP ;
Oyen, WJG ;
Nienhuijs, S ;
Hoekstra, HJ ;
Ruers, TJM ;
Wobbes, T .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (08) :662-664
[9]   PET CT imaging in patients undergoing sentinel node biopsy for melanoma [J].
Kell, M. R. ;
Ridge, J. A. ;
Joseph, N. ;
Sigurdson, E. R. .
EJSO, 2007, 33 (07) :911-913
[10]  
Klein M, 2000, NUKLEARMED, V39, P56
123